Jaguar Health, Inc. Contracts & Agreements

279 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Note Amendment, dated January 29, 2025, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Fourth ATM Amendment, dated November 13, 2024, to ATM Agreement by and among Jaguar Health, Inc., Ladenburg Thalmann & Co. Inc. and Lucid Capital Markets, LLC
Jaguar Health, Inc.
Pharmaceuticals
2024
Third ATM Amendment, dated July 17, 2024, to ATM Agreement by and among Jaguar Health, Inc., Ladenburg Thalmann & Co. Inc. and Lucid Capital Markets, LLC
Jaguar Health, Inc.
Pharmaceuticals
2024
Second Amendment to the At the Market Offering Agreement, dated May 23, 2024, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
2024
First Amendment to Amended and Restated License Agreement, dated March 16, 2024, by and between Napo Pharmaceuticals, Inc. and Nano Therapeutics S.p.A
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Streeterville Exchange Agreement
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2024
Form of PIPE Warrant Exchange Agreement
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2024
First Amendment to 200 Pine Street Office Lease, dated December 24, 2021, between Jaguar Health, Inc. and M & E, LLC
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Second Amendment to 200 Pine Street Office Lease, dated October 25, 2023, between Jaguar Health, Inc. and M & E, LLC
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2, dated September 29, 2023, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2, dated September 29, 2023, by and between Jaguar Health, Inc. and Uptown Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment, dated September 29, 2023, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2, dated September 29, 2023, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2023
Form of Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Exchange Agreement, dated September 29, 2023, by and between Jaguar Health, Inc. and Uptown Capital, LLC
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Binding Memorandum of Understanding, dated June 30, 2023, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc., Iliad Research and Trading, L.P., Uptown Capital, LLC and...
MOUs
Jaguar Health, Inc.
Pharmaceuticals
2023
Amendment No. 1 to Manufacturing and Supply Agreement, dated July 12, 2023, by and between Napo Pharmaceuticals, Inc. and Glenmark Life Sciences Limited
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Form of Exchange Agreement
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
First Amendment to the Standstill Agreement, dated June 28, 2023, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc., Iliad Research and Trading, L.P., Uptown Capital,...
Jaguar Health, Inc.
Pharmaceuticals
2023
Second Amendment to the Jaguar Health, Inc. New Employee Inducement Award Plan
Jaguar Health, Inc.
Pharmaceuticals
2023
Form of Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Form of Securities Purchase Agreement
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2023
Standstill Agreement
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Mutual Termination of License Agreement, dated as of January 31, 2023, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD, and Tao Wang
Termination Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2023
Form of Company Stock Option Cancellation Agreement
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2022
Securities Purchase Agreement, dated November 11, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Global Amendment, dated October 17, 2022, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
Amended and Restated License and Services Agreement, dated October 11, 2022, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD and Tao Wang
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Royalty Interest, dated August 24, 2022, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
UT
2022
Royalty Interest Purchase Agreement, dated August 24, 2022, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2022
Manufacturing Services Agreement, dated June 10, 2022, by and between Napo Pharmaceuticals, Inc. and Patheon Pharmaceuticals Inc
Services Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2022
Securities Purchase Agreement, dated August 18, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
First Amendment to the License and Services Agreement, dated August 18, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Amended and Restated License Agreement, dated July 19, 2022, by and between Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2022
License and Services Agreement, dated June 29 2022, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD and Tao Wang
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Global Amendment, dated April 14, 2022, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment, dated April 14, 2022, by and between Jaguar Health, Inc. and Uptown Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment, dated April 14, 2022, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment, dated April 14, 2022, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
First Amendment to the Jaguar Health, Inc. New Employee Inducement Award Plan
Jaguar Health, Inc.
Pharmaceuticals
2022
First Amendment to the At the Market Offering Agreement, dated February 2, 2022, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
2022
At The Market Offering Agreement, dated December 10, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement, dated September 13, 2021, by and between Jaguar Health, Inc. and the investors named therein
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
License Agreement, dated August 18, 2021, by and between Napo Pharmaceuticals, Inc. and Napo EU S.p.A
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Subscription Agreement, dated June 1, 2021, by and among Dragon SPAC S.p.A., Napo Pharmaceuticals, Inc. and Joshua Mailman
Subscription Agreements
Jaguar Health, Inc.
Pharmaceuticals
2021
Certain information marked as [****] has been excluded from this exhibit because it is both (i)not material and (ii)would be competitively harmful if publicly disclosed. OFFICE...
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
CONSENT TO SUBLEASE AGREEMENT
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2021
Certain information marked as [****] has been excluded from this exhibit because it is both (i)not material and (ii)would be competitively harmful if publicly disclosed....
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
Placement Agency Agreement, dated April 29, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Agency Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Form of Securities Purchase Agreement
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Common Stock Purchase Warrant, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Office Lease Agreement, dated March 25, 2021, between Jaguar Health, Inc. and M & E, LLC
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
First Amendment to the Equity Purchase Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Registration Rights Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Master Services Agreement, dated June 24, 2019, by and among Napo Pharmaceuticals, Inc., Integrium, LLC, and POC Capital, LLC
Services Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2021
Master Services Agreement, dated October 5, 2020, by and between Napo Pharmaceuticals, Inc. and Integrium, LLC
Services Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2021
Royalty Interest, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Securities Purchase Agreement, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Secured Promissory Note, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Note Purchase Agreement, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Security Agreement, dated January 19, 2021, by and between Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Placement Agency Agreement, dated January 13, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Agency Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Form of Securities Purchase Agreement
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Royalty Interest, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Securities Purchase Agreement, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Office Sublease Agreement, dated August 31, 2020, by and between Jaguar Health, Inc. and Peacock Construction, Inc
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Consent to Sublease Agreement, dated August 31, 2020, by and among M&E, LLC, Jaguar Health, Inc., and Peacock Construction, Inc
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Manufacturing and Supply Agreement, dated September 3, 2020, by and between Glenmark Life Sciences Limited and Napo Pharmaceuticals, Inc
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Fee Settlement Agreement, dated October 7, 2020, by and between Jaguar Health, Inc. and Atlas Sciences, LLC
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Royalty Interest, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Royalty Interest Purchase Agreement, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Exchange Agreement, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Stock Plan Agreement, dated October 6, 2020, by and between Jaguar Health, Inc. and PoC Capital, LLC
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
At The Market Offering Agreement, dated October 5, 2020, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Global Amendment, dated September 1, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Jaguar Health, Inc.
Pharmaceuticals
2020
Exchange Agreement, dated September 1, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Stock Plan Agreement for Payment of Consulting Services, dated September 1, 2020, by and among Jaguar Health, Inc., Sagard Capital Partners Management Corp. and Sagard Capital...
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Form of Severance and Change of Control Agreement
Change of Control Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
First Amendment to Purchase Agreement, dated June 26, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
First Amendment to Assignment Agreement, dated June 26, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC
Assignment Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2020
First Amendment to Royalty Interest Purchase Agreement and Related Documents, dated July 10, 2020, between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Jaguar Health, Inc. New Employee Inducement Award Plan
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Form of Notice of Grant of Stock Option and Stock Option Agreement under the Jaguar Health, Inc. New Employee Inducement Award Plan
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Form of Notice of Grant of Restricted Stock Units and Restricted Stock Unit Agreement under the Jaguar Health, Inc. New Employee Inducement Award Plan
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Form of Series 3 Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Form of Inducement Letter for Original Warrants
Jaguar Health, Inc.
Pharmaceuticals
2020
Form of Inducement Letter for Bridge Warrants
Jaguar Health, Inc.
Pharmaceuticals
2020
Purchase Agreement, dated May 12, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Assignment Agreement, dated May 12, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC
Assignment Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2020
Purchase Agreement, dated April 15, 2020, by and between Napo Pharmaceuticals, Inc. and Atlas Sciences, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
License Agreement, dated April 15, 2020, by and between Jaguar Health, Inc. and Atlas Sciences, LLC
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1945, as amended
Jaguar Health, Inc.
Pharmaceuticals
2020
Jaguar Health, Inc. 2014 Stock Incentive Plan as Amended and Restated Effective October 1, 2019
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Securities Purchase Agreement, dated March 23, 2020, by and between Jaguar Health, Inc. and the investors named therein
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Warrant Exercise and Preferred Stock Amendment Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and the Holder named therein
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Leak-Out Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and the Holder named therein
Jaguar Health, Inc.
Pharmaceuticals
2020
Equity Purchase Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Registration Rights Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Landlord Letter of Credit Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Charles Conte
Credit Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Royalty Interest, dated March 4, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Securities Purchase Agreement, dated March 4, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Form of Warrant Exercise Agreement by and between Jaguar Health, Inc. and the Holder named therein
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
First Amendment to the Exchange Agreement, dated January 22, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Form of Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Securities Purchase Agreement, dated December 20, 2019, by and between Jaguar Health, Inc. and the investors named therein
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Exchange Agreement, dated December 23, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Lock-Up Agreement, dated December 23, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Securities Purchase Agreement, dated November 13, 2019, by and between Jaguar Health, Inc. and the purchasers named therein
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
China Life Science Advisory Agreement, dated October 8, 2019, by and between Jaguar Health, Inc. and Angel Pond Capital LLC
Advisory Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Promissory Note, dated October 1, 2019, between Napo Pharmaceuticals, Inc. and Michael Tempesta
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
License Termination and Settlement Agreement, dated October 1, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Michael Tempesta
Termination Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Warrant Exercise Agreement, dated October 2, 2019, between Jaguar Health, Inc. and the purchaser named therein
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Amendment No. 1 to Registration Rights Agreement, dated May 30, 2019, by and between Jaguar Health, Inc. and Sagard Capital Partners, L.P
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
First Amendment to Landlord Letter of Credit & Warrant Issuance Agreement, dated September 16, 2019, by and between Jaguar Health, Inc. and Pacific Capital Management, LLC
Credit Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Promotion Letter, dated September 6, 2019
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Exchange Agreement, between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Form of Series 1 Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Series 2 Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Underwriting Agreement
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Form of Series 1 Warrant to purchase shares of common stock
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Series 2 Warrant to purchase shares of common stock
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Leak-out Agreement
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Underwriting Agreement
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Form of Series 1 Warrant to purchase shares of common stock
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Series 2 Warrant to purchase shares of common stock
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Warrant Agency Agreement between the Company and American Stock Transfer & Trust Company, LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Form of Amendment Agreement
Jaguar Health, Inc.
Pharmaceuticals
2019
Specimen Common Stock Certificate of Jaguar Health, Inc
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Guaranty and Suretyship Agreement, dated May 28, 2019, made by Jaguar Health, Inc
Guaranty Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Exchange Agreement, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Security Agreement, dated May 28, 2019, between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Security Agreement, dated May 28, 2019, between Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Form of LOC Common Stock Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Letter of Credit Cancellation & Warrant Issuance Agreement, dated March 29, 2019, by and between Jaguar Health, Inc. and the letter of credit beneficiary named therein
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Common Stock Purchase Agreement, dated April 1, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2019
Form of Placement Agent Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Placement Agency Agreement, dated March 24, 2019, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Agency Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Securities Purchase Agreement, dated March 24, 2019, by and between Jaguar Health, Inc. and the Investor
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Form of 75% Coverage Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Form of 125% Coverage Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Form of Common Stock Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Form of Securities Purchase Agreement
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Form of Registration Rights Agreement
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Common Stock Purchase Agreement, dated January 7, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2019
Suspension, Settlement and Termination Agreement, dated December 4, 2018, by and among Napo Pharmaceuticals, Inc., Jaguar Health, Inc. and SmartPharma, LLC
Termination Agreements
Jaguar Health, Inc.
Pharmaceuticals
NJ
2018
Standstill Agreement, dated October 1, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Form of Underwriting Agreement
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Form of Pre-Funded Warrant
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Common Stock Warrant, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Common Stock Warrant, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Note Purchase Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Note Purchase Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Registration Rights Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Registration Rights Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Common Stock Warrant, dated August 28, 2018, by and between Jaguar Health, Inc. and the holder named therein
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Office Lease Agreement, dated August 30, 2018, between Jaguar Health, Inc. and CA-Mission Street Limited Partnership
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Landlord Letter of Credit & Warrant Issuance Agreement, dated August 28, 2018, by and between Jaguar Health, Inc. and the letter of credit facilitator named therein
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Amended and Restated Security Agreement, dated July 31, 2017, by and among Napo Pharmaceuticals, Inc., Kingdon Capital Management, L.L.C., and the purchasers named therein
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Co-Promotion Agreement, dated June 28, 2018, by and between Napo Pharmaceuticals, Inc. and RedHill Biopharma, Inc
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Offer Letter, dated May 25, 2018
Jaguar Health, Inc.
Pharmaceuticals
2018
Offer Letter, dated May 25, 2018
Jaguar Health, Inc.
Pharmaceuticals
2018
Collaboration Agreement, dated December 13, 2017, by and between Jaguar Health, Inc. and Seed Mena Businessmen Services, LLC
Collaboration Agreements
Jaguar Health, Inc.
Pharmaceuticals
2018
Secured Promissory Note, dated March 21, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Series A Preferred Stock Purchase Agreement, dated March 23, 2018, by and between Jaguar Health, Inc. and Sagard Capital Partners, L.P
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Registration Rights Agreement, dated March 23, 2018, by and between Jaguar Health, Inc. and Sagard Capital Partners, L.P
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Form of Common Stock Purchase Agreement, dated March 23, 2018, by and between Jaguar Health, Inc. and the purchasers named therein
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Management Services Agreement, dated March 23, 2018, by and between Jaguar Health, Inc. and Sagard Capital Partners Management Corp
Management Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Securities Purchase Agreement, dated March 21, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Security Agreement, dated March 21, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Secured Promissory Note, dated February 26, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Securities Purchase Agreement, dated February 26, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Security Agreement, dated February 26, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Consent and Payoff Agreement, dated February 27, 2018, by and between Napo Pharmaceuticals, Inc. and the purchasers named therein
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Form of Second Amended Original Issue Discount Exchangeable Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Second Amendment to the Note Purchase Agreement and Notes and Payoff Agreement, dated February 16, 2018, by and among Jaguar Health, Inc. and the purchasers named therein
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Form of First Amended Original Issue Discount Exchangeable Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
First Amendment to the Note Purchase Agreement and Notes, dated December 29, 2017, by and among Jaguar Health, Inc. and the purchasers named therein
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Secured Promissory Note, dated December 8, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Securities Purchase Agreement, dated December 8, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Security Agreement, dated December 8, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Share Purchase Agreement, dated November 24, 2017, by and between Jaguar Health, Inc. and L2 Capital, LLC
Share Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2017
Common Stock Purchase Agreement, dated November 24, 2017, by and between Jaguar Health, Inc. and L2 Capital, LLC
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2017
Share Purchase Agreement, dated July 31, 2017, by and between Jaguar Health, Inc. and Invesco Asset Management Limited
Share Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Termination, Asset Transfer and Transition Agreement, dated September 22, 2017, by and between Napo Pharmaceuticals, Inc. and Glenmark Pharmaceuticals, Ltd
Transition Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Letter Agreement, dated October 25, 2017, by and between Jaguar Health, Inc. and Maxim Group LLC
Jaguar Health, Inc.
Pharmaceuticals
2017
Underwriting Agreement, dated September 29, 2017, by and between Jaguar Health, Inc. and Maxim Group LLC
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Letter Agreement, dated September 1, 2017, by and among Napo Pharmaceuticals, Inc., MEF I, L.P. and Riverside Merchant Partners
Jaguar Health, Inc.
Pharmaceuticals
2017
Letter Agreement, dated August 31, 2017, by and among Napo Pharmaceuticals, Inc., M. Kingdon Offshore Master Fund L.P., Kingdon Family Partnership, L.P. and Kingdon Credit Master...
Credit Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Letter Agreement, dated August 28, 2017, by and among Napo Pharmaceuticals, Inc., Dorsar Investment Company, Alco Investment Company and Two Daughters LLC
Jaguar Health, Inc.
Pharmaceuticals
2017
Letter Agreement, dated September 1, 2017, by and between Napo Pharmaceuticals, Inc. and Boies Schiller Flexner LLP
Jaguar Health, Inc.
Pharmaceuticals
2017
Letter Agreement, dated August 30, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Jaguar Health, Inc.
Pharmaceuticals
2017
[JAGUAR LETTERHEAD]
Jaguar Health, Inc.
Pharmaceuticals
2017
SECURED CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
SUBORDINATION AGREEMENT AND RIGHT TO PURCHASE DEBT
Subordination Agreement
Jaguar Health, Inc.
Pharmaceuticals
2017
SECURITY AGREEMENT
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
EMPLOYEE LEASING AND OVERHEAD ALLOCATION AGREEMENT
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
AMENDMENT NO. 1 TO EMPLOYEE LEASING AND OVERHEAD ALLOCATION AGREEMENT
Jaguar Health, Inc.
Pharmaceuticals
2017
NOTE PURCHASE AGREEMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
FORM OF EXCHANGEABLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
AMENDED AND RESTATED NOTE PURCHASE AGREEMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
FORM OF CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
LIMITED SUBORDINATION AGREEMENT
Subordination Agreement
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
SECURITY AGREEMENT
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
SETTLEMENT AND DISCOUNTED PAYOFF AGREEMENT
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
DEBT AND WARRANT SETTLEMENT AGREEMENT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
DEBT SETTLEMENT AGREEMENT
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
DEBT SETTLEMENT AGREEMENT
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
FORM OF ESCROW AGREEMENT
Escrow Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
FORM OF RESTRICTED STOCK UNIT INDEMNIFICATION AND FORFEITURE AGREEMENT
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
INVESTOR RIGHTS AGREEMENT by and between JAGUAR ANIMAL HEALTH, INC. and NANTUCKET INVESTMENTS LIMITED Dated as of March 31, 2017
Investor Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
*** TEXT OMITTED AND SUBMITTED PURSUANT TO CONFIDENTIAL TREATMENT REQUEST DISTRIBUTION AGREEMENT
Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
OH
2017
*** TEXT OMITTED AND SUBMITTED PURSUANT TO CONFIDENTIAL TREATMENT REQUEST LICENSE, DEVELOPMENT, CO-PROMOTION AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN JAGUAR ANIMAL HEALTH,...
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
[Jaguar ANIMAL HEALTH letterhead]
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
BINDING AGREEMENT OF TERMS FOR JAGUAR ANIMAL HEALTH, INC. ACQUISITION OF NAPO PHARMACEUTICALS, INC. FEBRUARY 8, 2017
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
COMMON STOCK PURCHASE WARRANT JAGUAR ANIMAL HEALTH, INC.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
COMMON STOCK PURCHASE WARRANT JAGUAR ANIMAL HEALTH, INC.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
COMMON STOCK PURCHASE WARRANT JAGUAR ANIMAL HEALTH, INC.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
COMMON STOCK PURCHASE WARRANT JAGUAR ANIMAL HEALTH, INC.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2016
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
*** TEXT OMITTED AND SUBMITTED SEPARATELY PURSUANT TO CONFIDENTIAL TREATMENT REQUEST JAGUAR ANIMAL HEALTH, INC. AND INTEGRATED ANIMAL NUTRITION AND HEALTH INC.
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
[Jaguar ANIMAL HEALTH letterhead]
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
RE: PROPOSED MERGER BETWEEN NAIROBI PHARMACEUTICALS INC (NAIROBI) AND JOHANNESBURG ANIMAL HEALTH INC (JOHANNESBURG OR JOBURG)
Merger Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2016
JAGUAR ANIMAL HEALTH, INC. 2014 STOCK INCENTIVE PLAN AS AMENDED AND RESTATED EFFECTIVE JUNE 14, 2016
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
IL
2016
COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
IL
2016
Jaguar Animal Health, Inc. 201 Mission Street 23rdfloor San Francisco, CA 94105 Tel: +1 ###-###-#### Fax: +1 ###-###-#### www.jaguaranimalhealth.com
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT AND WAIVER
Loan Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
FORM OF UNDERWRITING AGREEMENT between JAGUAR ANIMAL HEALTH, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2016
Patheon Pharmaceuticals Inc. (Patheon) Jaguar Animal Health (Client) By: /s/ Francis P. McCone By: /s/ Steven R. King Name: Francis P. McCone Name: Steven R. King Title: Secretary...
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
OH
2016
MANUFACTURE AND SUPPLY AGREEMENT
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
LOAN AND SECURITY AGREEMENT
Loan Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
SUBLEASE AGREEMENT
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
CONSENT TO SUBLEASE
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
FORM OF UNDERWRITING AGREEMENT between JAGUAR ANIMAL HEALTH, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
AMENDED AND RESTATED STANDBY BRIDGE FINANCING AGREEMENT Dated as of December 3, 2014 By and Among GPB LIFE SCIENCE HOLDINGS LLC (CO-LENDER) 31 GROUP LLC (CO-LENDER) and JAGUAR...
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
JAGUAR ANIMAL HEALTH, INC. FORM OF EXCHANGE WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Form of Representatives Warrant Agreement
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
FORM OF JAGUAR ANIMAL HEALTH, INC. JUNE/2014 CONVERTIBLE NOTE EXERCISE AMENDMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
FORM OF JAGUAR ANIMAL HEALTH, INC. WARRANT & NOTE EXERCISE AMENDMENT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
FORM OF JAGUAR ANIMAL HEALTH, INC. NOTE EXERCISE AMENDMENT AND CONVERSION AGREEMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
JAGUAR ANIMAL HEALTH, INC. CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
JAGUAR ANIMAL HEALTH, INC. COMMON STOCK WARRANT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
FORM OF JAGUAR ANIMAL HEALTH, INC. WARRANT EXERCISE AMENDMENT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
JAGUAR ANIMAL HEALTH, INC. FORM OF AMENDED AND RESTATED EXCHANGE WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
JAGUAR ANIMAL HEALTH, INC. EXCHANGE WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
AMENDMENT NO. 1 TO AMENDED AND RESTATED LICENSE AGREEMENT
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
FORM OF CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
JAGUAR ANIMAL HEALTH, INC. FORM OF CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
JAGUAR ANIMAL HEALTH, INC. FORM OF COMMON STOCK WARRANT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
Jaguar Animal Health, Inc. 185 Berry Street, Suite 1300 San Francisco, CA 94107 Tel: +1 ###-###-#### Fax: +1 ###-###-#### www.jaguaranimalhealth.com
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
JAGUAR ANIMAL HEALTH, INC. 2014 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
JAGUAR ANIMAL HEALTH, INC. FORM OF WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2014
Common Stock JAGUAR ANIMAL HEALTH, INC. UNDERWRITING AGREEMENT
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2014
Jaguar Animal Health, Inc. 185 Berry Street, Suite 1300 San Francisco, CA 94107 Tel: +1 ###-###-#### Fax: +1 ###-###-#### www.jaguaranimalhealth.com
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
NAPO PHARMACEUTICALS, INC. 185 Berry Street, Suite 1300 San Francisco, CA 94107
Jaguar Health, Inc.
Pharmaceuticals
NY
2014
LINE OF CREDIT LOAN AGREEMENT
Loan Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
JAGUAR ANIMAL HEALTH, INC. FORM OF COMMON STOCK WARRANT
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2014
INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2014
FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2014
Jaguar Animal Health, Inc. 2013 Equity Incentive Plan November 1, 2013
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
2014
JAGUAR ANIMAL HEALTH, INC. FORM OF NOTICE OF GRANT OF STOCK OPTION
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
JAGUAR ANIMAL HEALTH, INC. FORM OF NOTICE OF GRANT OF RESTRICTED STOCK UNITS
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
JAGUAR ANIMAL HEALTH, INC. 2014 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
JAGUAR ANIMAL HEALTH, INC. FORM OF NOTICE OF GRANT OF STOCK OPTION
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
JAGUAR ANIMAL HEALTH, INC. FORM OF NOTICE OF GRANT OF RESTRICTED STOCK
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
JAGUAR ANIMAL HEALTH, INC. FORM OF NOTICE OF GRANT OF RESTRICTED STOCK UNITS
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
EXHIBIT A TO THE OFFER LETTER EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT AND ARBITRATION AGREEMENT
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. 185 Berry Street, Suite 1300 San Francisco, CA 94107 Tel: +1 ###-###-#### Fax: +1 ###-###-#### www.jaguaranimalhealth.com
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
EXHIBIT A TO THE OFFER LETTER EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT AND ARBITRATION AGREEMENT
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
EXHIBIT A TO THE OFFER LETTER EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT AND ARBITRATION AGREEMENT
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014